Cytotoxicity and cellular accumulation of palladium(II) complexes of tetracyclines

Chemistry and Biodiversity

Volumn 5, Issue 10, 2008, Pages 2124-2130

  de Paula, Flávia C S ^a   Guerra, Wendell ^a   Silva, Iara R ^a   Silveira, Josianne N ^a   Botelho, Françoise Vasconcelos ^a   Vieira, Leda Q ^a   Pereira Maia, Elene C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; DOXYCYCLINE PALLADIUM COMPLEX; PALLADIUM COMPLEX; TETRACYCLINE PALLADIUM COMPLEX; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ORGANOMETALLIC COMPOUND; PALLADIUM; TETRACYCLINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CELL LEVEL; CELL STRAIN K 562; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MACROPHAGE; ANIMAL; C57BL MOUSE; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; FEMALE; IC 50; MALE; METABOLISM; MOUSE; PERITONEUM MACROPHAGE; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; K562 CELLS; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; ORGANOMETALLIC COMPOUNDS; PALLADIUM; TETRACYCLINES; TIME FACTORS;

EID: 58149335243     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200890193     Document Type: Article

References (24)

1. I. Chopra, P. M. Hawkey, M. J. Hinton, J. Antimicrob. Chemother. 1992, 29, 245.
2. I. Chopra, Drug Resist. Updates 2002, 5, 119.
3. D. M. Shales, Curr. Opin. Invest. Drugs 2006, 7, 167.
4. L. Lambs, M. Brion, G. Berthon, Inorg. Chim. Acta 1983, 106, 151.
5. M. Brion, G. Berthon, J. B. Fourtellan, Inorg. Chim. Acta 1981, 55, 47.
6. L. Lambs, M. Venturini, B. Decock-Le Révérend, H. Kozlowski, G. Berthon, J. Inorg. Biochem. 1988, 33, 193.
7. M. Egeblad, Z. Werb, Nat. Rev. Cancer 2002, 2, 161.
8. C. M. Overall, C. Lopez-Otin, Nat. Rev. Cancer 2002, 2, 657.
9. R. A. Garcia, D. P. Pantazatos, C. R. Gessner, K. V. Go, V. L. Woods Jr., F. J. Villarreal, Mol. Pharmacol. 2005, 67, 1128.
10. A. M. Khan, J. Musarrat, Int. J. Biol. Macromol. 2003, 33, 49.
11. A. C. Caires, Anti-Cancer Agents Med. Chem. 2007, 7, 484;
12. S. Ray, R. Mohan, J. K. Singh, M. K. Samantaray, M. M. Shaikh, D. Panda, P. Ghosh, J. Am. Chem. Soc. 2007, 129, 15042;
13. A. Divsalar, A. A. Saboury, R. Yousefi, A. A. Moosavi-Movahedi, H. Mansoori-Torshizi, Int. J. Biol. Macromol. 2007, 40, 381;
14. A. I. Matesanz, P. Souza, J. Inorg. Biochem. 2007, 101, 245;
15. M. Howe-Grant, K. C. Wu, W. R. Bauer, S. J. Lippard, Biochemistry 1976, 15, 4339.
16. a) E. Chartone-Souza, T. L. Loyola, M. Bucciarelli-Rodriguez, M. A. Menezes, N. A. Rey, E. C. Pereira-Maia, J. Inorg. Biochem. 2005, 99, 1001;
17. b) W. Guerra, E. A. Azevedo, A. R. S. Monteiro, E. Chartone-Souza, A. M. A. Nascimento, M. Bucciarelli-Rodriguez, A. P. S. Fontes, L. Le Moyec, E. C. Pereira-Maia, J. Inorg. Biochem. 2005, 99, 2348;
18. c) W. Guerra, I. R. Silva, E. A. Azevedo, A. R. S. Monteiro,M. Bucciarelli-Rodriguez, E. Chartone-Souza, J. N. Silveira, A. P. S. Fontes, E. C. Pereira-Maia, J. Braz. Chem. Soc. 2006, 17, 1627.
19. A. Sigler, P. Schubert, W. Hillen, M. Niederwei, Eur. J. Biochem. 2000, 267, 527;
20. A. Yamaguchi, H. Ohmori, M. J. Kaneko-Ohdera, T. Nomura, T. Sawai, Antimicrob. Agents Chemother. 1991, 35, 53.
21. E. Pereira-Maia, A. Garnier-Suillerot, J. Biol. Inorg. Chem. 2003, 8, 626.
22. F. H. Shirazi, J. M. Molepo, D. J. Stewart, C. E. Ng, G. P. Raaphorst, R. Goel, Toxicol. Appl. Pharmacol. 1996, 140, 211.
23. M. Mishima,G. Samimi, A. Kondo, X. Lin, S. B. Howell, Eur. J. Cancer 2002, 38, 1405;
24. A. R. Ghezzi, M. Aceto, C. Cassino, E. Gabano, D. Osella, J. Inorg. Biochem. 2004, 98, 73.